Dna repair drugs market analysis | Coherent Market Insights

1
Coherent Marketing Insights

• Market Research Business Consulting Services

• https//www.coherentmarketinsights.com/

• Covid-19 Impact Tracker

2

• DNA REPAIR DRUGS MARKET ANALYSIS
• DNA Repair Drugs Market, by Drug (Niraparib
  (Zejula), Olaparib (Lynparza), Rucaparib
  (Rubraca), Talazoparib (Talzenna), and Others),
  by Application (Ovarian cancer, Fallopian Tube
  cancer, Peritoneal cancer, Breast cancer and
  Gastric cancer) by Distribution Channel (Hospital
  Pharmacies, Retail Pharmacies, and Online
  Pharmacies), and by Region (North America, Latin
  America, Europe, Asia Pacific, Middle East, and
  Africa) Size, Share, Outlook, and Opportunity
  Analysis, 2018 2026

3

• DNA repair drugs are used in repairing damaged
  DNA and for treating cancers. DNA damage results
  in genetic disorders, however the human body has
  its own mechanisms to correct the DNA sequence.
  DNA repair drugs such as PARP inhibitors and
  other DNA repair drugs help to treat diseases
  with genetic aberrations.
• The global DNA repair drugs market size was
  valued at US 461.3 Mn in 2017, and is expected
  to exhibit a CAGR of 32.4 over the forecast
  period (20182026).

4
Figure 1. Global DNA Repair Drugs Market Value
(US Mn), by Region, 2018
5

• Increasing incidence of cancer, rising government
  initiatives to promote awareness for cancer
  treatment, and expansion strategies by
  manufacturers to increase and expand their
  product portfolio in the international markets
  are factors propelling growth of the global DNA
  repair drugs market
• Increasing incidence of cancer is expected to
  drive the global DNA repair drugs market growth
  over the forecast period. According to the World
  Cancer Research Fund Internationals report in
  2018, breast cancer accounted for the second
  highest number of cancer cases (2,088,849 new
  cases) across the globe in 2018. According to
  GLOBOCAN, 43.6 new cases of breast cancer were
  registered in Asia Pacific in 2018.
• Moreover, increasing drug approval by key players
  in order to address demand for efficient
  therapeutics, is expected to propel growth of the
  market over the forecast period. In October 2018,
  Pfizer Inc. received the U.S. Food and Drug
  Administration (FDA) approval for Talazoparib
  (Talzenna) for treating patients with HER2
  (negative locally advanced or metastatic breast
  cancer).

6
Figure 2. Global DNA Repair Drugs Market Share
(), by Drug Type, (2018-2026)

7
Rising prevalence of cancer, as well as
increasing collaborations and acquisitions by key
players is expected to boost the market growth

• North America is expected to dominate the global
  DNA repair drugs market over the forecast period
  owing to increasing incidence of cancer.
  According to the American Cancer Society, in
  2018, an estimated 266,120 new cases of invasive
  breast cancer were diagnosed in the U.S.
  Moreover, increasing demand for cancer treatments
  is expected to drive growth of the DNA repair
  drugs market in the region.
• Market players are engaged in research and
  development activities in order to meet the
  rising demand DNA repair drugs. In May 2019,
  Clovis Oncology, Inc., collaborated with
  Bristol-Myers Squibb Company and Foundation
  Medicine Inc. to initiate phase II study for
  evaluating rucaparib in combination with
  nivolumab in patients with high-grade serous
  carcinoma (HGSC) or endometroid ovarian cancer.

8
Key Players

• Major players operating in the global DNA repair
  drugs market are AstraZeneca Plc., Johnson
  Johnson, GlaxoSmithKline plc., Pfizer, Inc.,
  Clovis Oncology Inc., AbbVie Inc., Bristol -
  Myers Squibb, Merck KGaA, Genentech, Inc., Repare
  Therapeutics Inc., Karyopharm Therapeutics Inc.,
  Ono Pharmaceutical Co., LTD., and Jiangsu Hengrui
  Medicine Co., Ltd.

9

• Request Sample Report
• Request Customization
• Download PDF Brochure
• Talk to Analyst
• Referance https//www.coherentmarketinsights.com/
  market-insight/dna-repair-drugs-market-2617

10
About Us

• Coherent Market Insights is a global market
  intelligence and consulting organization focused
  on assisting our plethora of clients achieve
  transformational growth by helping them make
  critical business decisions. We are headquartered
  in India, having office at global financial
  capital in the U.S. Our client base includes
  players from across all business verticals in
  over 150 countries worldwide.
• What We ProvideCustomized Market Research
  AnalysisIndustry Analysis ServicesBusiness
  Consulting ServicesLong Term Engagement
  ModelCountry Specific Analysis

11
Contact Us

• Mr. Shah
• Coherent Market Insights Pvt. LTD.Coherent
  Market Insights 1001 4th Ave, 3200 Seattle, WA
  98154, U.S.Phone [phone]
• Email sales_at_coherentmarketinsights.com

12
Thank You

• Kindly Follow CMI Social Media Profiles for the
  latest Company Updates.
• Facebook
• Linkedin
• Twitter
• https//www.coherentmarketinsights.com/